Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial

The purpose of this study was to assess the pharmacokinetic (PK) characteristics, clinical efficiency, and pharmacoeconomic parameters of piperacillin/tazobactam administered by extended infusion (EI) or intermittent infusion (II) in the treatment of hospital-acquired pneumonia (HAP) in critically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, H., Lv, Y., Wang, D., Xue, J., Yan, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309263/
https://www.ncbi.nlm.nih.gov/pubmed/27796647
http://dx.doi.org/10.1007/s10096-016-2819-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309263/
https://www.ncbi.nlm.nih.gov/pubmed/27796647
http://dx.doi.org/10.1007/s10096-016-2819-1

Ejemplares similares